Cancer vaccine ‘could be available by 2030’

Cancer vaccines could be given to patients in the next decade, the team behind the Pfizer/BioNTech Covid jab predict.

Cancer vaccines could be given to patients in the next decade, the team behind the Pfizer/BioNTech Covid jab predict.

Professors Ugur Sahin and Ozlem Tureci said the development and success of their coronavirus vaccine has boosted their work on one for cancer, The Sun reported.

Prof Tureci told the BBC: “We have learned how to better, faster manufacture vaccines. We have learned how the immune system reacts.

“This will definitely accelerate also our cancer vaccine.

Stream the latest health news with Flash. 25+ news channels in 1 place. New to Flash? Try 1 month free. Offer ends 31 October, 2022 >

A woman is seen receiving the Pfizer-BioNtech Covid vaccine. (Photo by JACK GUEZ / AFP)

“As scientists we are always hesitant to say we will have a cure for cancer.

“We have a number of breakthroughs and we will continue to work on them.”

She said the developments also helped regulators deal with vaccines.

Asked when cancer jabs could be available, Prof Sahin said it could be “before 2030”.

The scientist couple co-founded BioNTech in Mainz, Germany, in 2008, and worked to pioneer cancer immunotherapies tailored to individual patients.

Their use of mRNA technology came into its own in the pandemic, and the couple said that experience has helped to spur on their work.

This story was originally published by The Sun and was reproduced with permission

Originally published as Cancer vaccine ‘could be available by 2030’